Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare CVE:EMHTSE:FAR On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeEMHEmerald Health TherapeuticsC$0.26-3.8%C$0.26C$0.15▼C$0.53C$52.28MN/A644,760 shs384,329 shsFARForaco InternationalC$1.79-0.6%C$1.89C$1.72▼C$2.96C$125.61M1.2569,535 shs9,967 shsThe Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceEMHEmerald Health Therapeutics0.00%0.00%0.00%0.00%0.00%FARForaco International-0.56%-4.79%-4.28%-10.50%-36.52%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationEMHEmerald Health TherapeuticsN/AN/AN/AN/AN/AN/AN/AN/AFARForaco International1.5216 of 5 stars2.00.00.80.01.13.31.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceEMHEmerald Health Therapeutics 0.00N/AN/AN/AFARForaco International 0.00N/AC$4.25137.43% UpsideCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookEMHEmerald Health TherapeuticsC$13.02M4.02C$0.33 per share0.78C$0.40 per share0.64FARForaco InternationalC$227.57M0.55C$0.32 per share5.54C$0.96 per share1.87Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateEMHEmerald Health TherapeuticsN/A-C$0.70N/A∞N/AN/AN/AN/AN/AFARForaco InternationalC$19.15MC$0.384.65∞N/A8.42%31.54%13.19%N/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthEMHEmerald Health TherapeuticsN/AN/AN/AN/AN/AFARForaco InternationalN/A2.52%N/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioEMHEmerald Health Therapeutics35.452.972.61FARForaco International115.591.430.88Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipEMHEmerald Health TherapeuticsN/AFARForaco International5.03%Insider OwnershipCompanyInsider OwnershipEMHEmerald Health TherapeuticsN/AFARForaco International35.74%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableEMHEmerald Health Therapeutics161205.03 millionN/ANot OptionableFARForaco International1,00070.17 millionN/ANot OptionableCMET, FAR, EMH, and ZNWD HeadlinesRecent News About These CompaniesForaco International Announces Additions and Diversification of Senior Management TeamMay 6, 2025 | finance.yahoo.comFY2025 Earnings Estimate for TSE:FAR Issued By DesjardinsMay 6, 2025 | marketbeat.comQ3 Earnings Forecast for TSE:FAR Issued By Clarus SecuritiesMay 6, 2025 | marketbeat.comDesjardins Predicts Higher Earnings for Foraco InternationalMay 4, 2025 | marketbeat.comForaco International SA (FRACF) Q1 2025 Earnings Call Highlights: Navigating Challenges with ...May 1, 2025 | gurufocus.comForaco International Reports Q1 2025 ResultsApril 30, 2025 | goldseiten.deFORACO PROVIDES NOTICE OF 2025 Q1 RESULTS & CONFERENCE CALLApril 23, 2025 | finance.yahoo.comForaco Announces Election of DirectorsApril 23, 2025 | finance.yahoo.comThose who invested in Foraco International (TSE:FAR) five years ago are up 552%April 17, 2025 | finance.yahoo.comInsider Buying: Foraco International SA (TSE:FAR) Director Purchases 5,000 Shares of StockApril 1, 2025 | insidertrades.comWilliam Warren Holmes Purchases 5,000 Shares of Foraco International SA (TSE:FAR) StockMarch 25, 2025 | insidertrades.comRetail investors account for 60% of Foraco International SA's (TSE:FAR) ownership, while insiders account for 36%March 18, 2025 | finance.yahoo.comForaco International SA (TSE:FAR) Director William Warren Holmes Purchases 5,000 SharesMarch 5, 2025 | insidertrades.comForaco International Full Year 2024 Earnings: Misses ExpectationsFebruary 24, 2025 | finance.yahoo.comEarnings To Watch: Foraco International SA (TSX:FAR) Reports Q4 2024 ResultFebruary 18, 2025 | gurufocus.comWhy The 28% Return On Capital At Foraco International (TSE:FAR) Should Have Your AttentionFebruary 14, 2025 | uk.finance.yahoo.comFORACO PROVIDES NOTICE OF 2024 Q4 RESULTS & CONFERENCE CALLFebruary 11, 2025 | finance.yahoo.comJanuary 2025 TSX Penny Stocks With Promising PotentialJanuary 24, 2025 | finance.yahoo.comForaco International Wins Innovation AwardNovember 5, 2024 | goldseiten.deForaco International reports Q3 2024October 30, 2024 | newswire.caForaco International SA (TSX:FAR) Q3 2024 Earnings Report Preview: What To Look ForOctober 29, 2024 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesWhy Wells Fargo Is Buying $40 Billion of Its Own StockBy Gabriel Osorio-Mazilli | May 6, 2025View Why Wells Fargo Is Buying $40 Billion of Its Own StockBest Defense Stocks in 2025... So FarBy Chris Markoch | April 28, 2025View Best Defense Stocks in 2025... So Far2 Reasons Netflix’s 40% Rally Is Far From OverBy Sam Quirke | May 20, 2025View 2 Reasons Netflix’s 40% Rally Is Far From OverAnalysts See $4,000 Gold: 3 Ways to Invest at Varied Risk LevelsBy Leo Miller | May 2, 2025View Analysts See $4,000 Gold: 3 Ways to Invest at Varied Risk LevelsThe 6 Best Energy Stocks to Buy NowBy Dan Schmidt | April 25, 2025View The 6 Best Energy Stocks to Buy NowCMET, FAR, EMH, and ZNWD Company DescriptionsEmerald Health Therapeutics CVE:EMHC$0.26 -0.01 (-3.77%) As of 04/26/2021Emerald Health Therapeutics, Inc., together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc. and changed its name to Emerald Health Therapeutics, Inc. in June 2015. Emerald Health Therapeutics, Inc. is headquartered in Vancouver, Canada.Foraco International TSE:FARC$1.79 -0.01 (-0.56%) As of 05/23/2025 04:15 PM EasternForaco International SA is the business of providing mineral and water drilling services and hydraulic drilling. It specializes in drilling in harsh environments and isolated locations including desert, and mountainous regions. The principal sources of revenue consist of drilling contracts for companies involved in mining and water exploration. The group has its operations in Europe, the Middle East and Africa, North America, South America and the Asia Pacific. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 05/19 - 05/23 Trade Desk Silences Critics; Recovery Looks Poised to Continue Booz Allen Hamilton Earnings: 3 Bullish Signals for BAH Stock Turbulence for Joby Shares: What's Behind the Recent Dip? Pfizer's 7.5% Dividend: Income Haven or House of Cards? TJX Stock Price Stumble Is Your Chance to Pick Up a Bargain These ETFs Provide Easy Exposure to Growing International Markets Advance Auto Parts Jumps on Surprise Earnings Beat Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
